Attagene has developed a pathway profiling technology to evaluate the impact of pharmaceuticals, environmental chemicals and natural products on over 100 transcription factors and 48 nuclear receptors.
Employment range in NC
Primary site activity
Potential end market(s)
Products on market
The proprietary FACTORIAL platform is the first to market multiplex reporter technology. We use this platform to predict therapeutic activity and adverse effects of compounds.